Difference between revisions of "Abiraterone"
Jump to navigation
Jump to search
(Created page with "'''Abiraterone''' is an androgen synthesis inhibitor used to treat prostate cancer.<ref name=pmid23887973>{{Cite journal | last1 = Mitsiades | first1 = N. | title = A roa...") |
|||
| Line 4: | Line 4: | ||
{{Reflist|1}} | {{Reflist|1}} | ||
[[Category: | [[Category:Genitourinary pathology]] | ||
[[Category:Clinical]] | [[Category:Clinical]] | ||
Revision as of 03:00, 20 May 2016
Abiraterone is an androgen synthesis inhibitor used to treat prostate cancer.[1]
References
- ↑ Mitsiades, N. (Aug 2013). "A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer.". Cancer Res 73 (15): 4599-605. doi:10.1158/0008-5472.CAN-12-4414. PMID 23887973.